ETFs seeking to replicate the performance of Biotech Large & Mid Cap stocks indices experienced a good market session yesterday with a positive performance standing at +1,84% despite negative flows of $-83,56M. This brought the year-to-date cumulated performance positive again at +0,79%. Over the same period, the segment collected $+237,47M of cumulated flows. Nevertheless, this was the fourth consecutive days of outflows for the segment. 11 funds tracking 6 indices are included in the segment for a total of $10,5Bn of assets under management.